Immunology:
Our other therapy areas

    • {%itemName%}
        {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%subBrandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%productMenuItems%}
    • {%itemKeyName%} {%itemBadges%} {%arrowSpan%}
      {%selfProduct%}
    • {%itemName%}
      • {%countries%}
    • {%allMenuItem%}
      • {%languages%}

      • This website is for UK Healthcare Professionals only

      UK-RNQD-210277. DOP: December 2021.

      HCP resources for your patients

      Patient Booklet for Adults

      This guide has been designed to help your adult patients navigate their RINVOQ journey step-by-step.

      DOWNLOAD THE PATIENT GUIDE FOR ADULTS

      Patient Booklet for Adolescents

      This guide has been designed to help adolescent patients navigate their RINVOQ journey step-by-step.

      DOWNLOAD THE PATIENT GUIDE FOR ADOLESCENTS

      RINVOQ Patient Alert Card

      This contains important information for your patients and their carers. The Patient Alert Card must always be sent to the patient along with the Patient Guide.

      DOWNLOAD THE PATIENT ALERT CARD

      Printed Materials

      For patients who prefer not to receive information digitally, all of the items are available as hard copy materials.

      To receive printed versions of any of these materials for your patients, submit your details on the Contact Us page. 

      1. RINVOQ Summary of Product Characteristics

      UK-RNQD-210283. Date of preparation: January 2022

      Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.
      Adverse events should also be reported to AbbVie on GBPV@abbvie.com